Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Plaque psoriasis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ADMIT
- Sponsors AbbVie
- 12 Jun 2018 Status changed from not yet recruiting to recruiting.
- 27 Apr 2018 Planned initiation date changed from 31 Mar 2018 to 31 May 2018.
- 20 Feb 2018 Planned initiation date changed from 15 Jan 2018 to 31 Mar 2018.